(TEX) Terex - Overview
Stock: Crushers, Screens, Cranes, Lifts, Crushers
| Risk 5d forecast | |
|---|---|
| Volatility | 70.8% |
| Relative Tail Risk | -10.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.05 |
| Alpha | 36.26 |
| Character TTM | |
|---|---|
| Beta | 1.590 |
| Beta Downside | 1.528 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.25% |
| CAGR/Max DD | 0.16 |
EPS (Earnings per Share)
Revenue
Description: TEX Terex January 12, 2026
Terex Corporation (NYSE:TEX) designs, manufactures, and finances a broad portfolio of materials-processing and mobile-elevating work platform (AWP) equipment for construction, mining, recycling, and infrastructure markets. Its Materials Processing (MP) segment sells crushers, screens, conveyors, concrete mixers, and related parts under brands such as Powerscreen, Fuchs, and ZenRobotics, while the AWP segment offers aerial lifts, telehandlers, and scissor lifts under the Terex and Genie names. The company also operates an ESG-focused line that provides refuse-collection bodies, balers, and waste-hauler software through brands like Heil and Marathon.
Key operating metrics from the most recent fiscal year (2023) show revenue of roughly **$2.2 billion**, an **operating margin of 7 %**, and a **free-cash-flow generation of $200 million**. The order backlog stood at about **$1.1 billion**, indicating near-term demand continuity. Terex’s exposure to construction spending is a primary driver; U.S. non-residential construction outlays grew **~3 % YoY** in 2023, while the 2021 Infrastructure Investment and Jobs Act is expected to sustain multi-year growth in heavy-equipment orders.
Sector-level trends reinforce the outlook: the global construction-machinery market is projected to expand at a **CAGR of ~5 %** from 2024-2029, propelled by emerging-market urbanization and advanced-technology adoption (e.g., AI-enabled recycling systems like ZenRobotics). However, Terex’s performance remains sensitive to cyclical capital-expenditure cycles, commodity-price volatility, and the pace of infrastructure funding approvals.
For a deeper, data-driven assessment of TEX’s valuation and risk profile, you might find the analytical tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 221.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.12 > 1.0 |
| NWC/Revenue: 28.37% < 20% (prev 24.32%; Δ 4.05% < -1%) |
| CFO/TA 0.07 > 3% & CFO 412.0m > Net Income 221.0m |
| Net Debt (-766.0m) to EBITDA (776.0m): -0.99 < 3 |
| Current Ratio: 2.30 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (67.6m) vs prev -1.02% < -2% |
| Gross Margin: 19.39% > 18% (prev 0.21%; Δ 1918 % > 0.5%) |
| Asset Turnover: 91.35% > 50% (prev 89.47%; Δ 1.88% > 0%) |
| Interest Coverage Ratio: 1.96 > 6 (EBITDA TTM 776.0m / Interest Expense TTM 265.0m) |
Altman Z'' 3.69
| A: 0.25 (Total Current Assets 2.73b - Total Current Liabilities 1.19b) / Total Assets 6.14b |
| B: 0.32 (Retained Earnings 1.96b / Total Assets 6.14b) |
| C: 0.09 (EBIT TTM 519.0m / Avg Total Assets 5.93b) |
| D: 0.39 (Book Value of Equity 1.58b / Total Liabilities 4.04b) |
| Altman-Z'' Score: 3.69 = AA |
Beneish M -3.04
| DSRI: 0.95 (Receivables 643.0m/643.0m, Revenue 5.42b/5.13b) |
| GMI: 1.07 (GM 19.39% / 20.82%) |
| AQI: 0.92 (AQ_t 0.43 / AQ_t-1 0.47) |
| SGI: 1.06 (Revenue 5.42b / 5.13b) |
| TATA: -0.03 (NI 221.0m - CFO 412.0m) / TA 6.14b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of TEX shares?
Over the past week, the price has changed by +10.34%, over one month by +14.15%, over three months by +51.62% and over the past year by +56.44%.
Is TEX a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 9
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the TEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67.5 | -2.6% |
| Analysts Target Price | 67.5 | -2.6% |
| ValueRay Target Price | 78.5 | 13.4% |
TEX Fundamental Data Overview February 12, 2026
P/E Forward = 12.7877
P/S = 1.4667
P/B = 3.886
P/EG = 1.643
Revenue TTM = 5.42b USD
EBIT TTM = 519.0m USD
EBITDA TTM = 776.0m USD
Long Term Debt = 2.58b USD (from longTermDebt, last fiscal year)
Short Term Debt = 6.00m USD (from shortTermDebt, last quarter)
Debt = 6.00m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -766.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.07b USD (7.84b + Debt 6.00m - CCE 772.0m)
Interest Coverage Ratio = 1.96 (Ebit TTM 519.0m / Interest Expense TTM 265.0m)
EV/FCF = 25.35x (Enterprise Value 7.07b / FCF TTM 279.0m)
FCF Yield = 3.95% (FCF TTM 279.0m / Enterprise Value 7.07b)
FCF Margin = 5.15% (FCF TTM 279.0m / Revenue TTM 5.42b)
Net Margin = 4.08% (Net Income TTM 221.0m / Revenue TTM 5.42b)
Gross Margin = 19.39% ((Revenue TTM 5.42b - Cost of Revenue TTM 4.37b) / Revenue TTM)
Gross Margin QoQ = 18.82% (prev 20.26%)
Tobins Q-Ratio = 1.15 (Enterprise Value 7.07b / Total Assets 6.14b)
Interest Expense / Debt = -750.0% (Interest Expense -45.0m / Debt 6.00m)
Taxrate = 21.0% (US default 21%)
NOPAT = 410.0m (EBIT 519.0m * (1 - 21.00%))
Current Ratio = 2.30 (Total Current Assets 2.73b / Total Current Liabilities 1.19b)
Debt / Equity = 0.00 (Debt 6.00m / totalStockholderEquity, last quarter 2.10b)
Debt / EBITDA = -0.99 (Net Debt -766.0m / EBITDA 776.0m)
Debt / FCF = -2.75 (Net Debt -766.0m / FCF TTM 279.0m)
Total Stockholder Equity = 1.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.72% (Net Income 221.0m / Total Assets 6.14b)
RoE = 11.16% (Net Income TTM 221.0m / Total Stockholder Equity 1.98b)
RoCE = 11.38% (EBIT 519.0m / Capital Employed (Equity 1.98b + L.T.Debt 2.58b))
RoIC = 9.05% (NOPAT 410.0m / Invested Capital 4.53b)
WACC = 11.77% (E(7.84b)/V(7.84b) * Re(11.78%) + (debt cost/tax rate unavailable))
Discount Rate = 11.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.63%
[DCF Debug] Terminal Value 60.69% ; FCFF base≈245.9m ; Y1≈197.7m ; Y5≈135.3m
Fair Price DCF = 19.82 (EV 1.48b - Net Debt -766.0m = Equity 2.25b / Shares 113.5m; r=11.77% [WACC]; 5y FCF grow -23.47% → 2.90% )
EPS Correlation: -3.86 | EPS CAGR: 11.69% | SUE: -0.05 | # QB: 0
Revenue Correlation: 70.09 | Revenue CAGR: 7.57% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.97 | Chg30d=-0.004 | Revisions Net=+1 | Analysts=8
EPS current Year (2026-12-31): EPS=5.43 | Chg30d=-0.215 | Revisions Net=-2 | Growth EPS=+10.2% | Growth Revenue=+8.3%
EPS next Year (2027-12-31): EPS=6.64 | Chg30d=-0.182 | Revisions Net=+0 | Growth EPS=+22.1% | Growth Revenue=+9.1%